about
Critical appraisal of the recent data published on the link between insulin and cancer.Treat-to-target trials in diabetes.India suspends pioglitazone: is it justified?Hypoglycaemia and CV risk: Perceptions and reality.Is insulin degludec a more effective treatment for patients using high doses of insulin glargine but not attaining euglycemia? Some case reports from India.Quantitative vibration perception threshold in assessing diabetic neuropathy: is the cut-off value lower for Indian subjects? [Q-VADIS Study].Liraglutide and Dulaglutide therapy in addition to SGLT-2 inhibitor and metformin treatment in Indian type 2 diabetics: a real world retrospective observational study.Sodium-Glucose Cotransporter-2 Inhibitors (SGLT-2i) Reduce Hospitalization for Heart Failure Only and Have No Effect on Atherosclerotic Cardiovascular Events: A Meta-Analysis.Redefining Cardiovascular (CV) Death as a primary end point component in Cardiovascular Outcome TrialsIs it worth CANVASing for CREDENCE? A benefit-risk analysisMeta-analyses of the effects of DPP-4 inhibitors, SGLT2 inhibitors and GLP1 receptor analogues on cardiovascular death, myocardial infarction, stroke and hospitalization for heart failureLinear Regression Analysis to predict the number of deaths in India due to SARS-CoV-2 at 6 weeks from day 0 (100 cases - March 14th 2020)Rapid sputum testing and not thermal screening alone should be the first-line screening test at airports: A Bayesian analysisEstimation of effects of nationwide lockdown for containing coronavirus infection on worsening of glycosylated haemoglobin and increase in diabetes-related complications: A simulation model using multivariate regression analysisThe role of corticosteroids in the management of critically ill patients with coronavirus disease 2019 (COVID-19): A meta-analysisTeneligliptin and "Thorough QTc study": thorough enough?Translating the statistical benefits of SGLT-2 inhibitors on Cardio-renal outcomes into clinical practiceThe effect of angiotensin converting enzyme inhibitors and angiotensin receptor blockers on death and severity of disease in patients with coronavirus disease 2019 (COVID-19): A meta-analysisFrequency of testing for COVID 19 infection and the presence of higher number of available beds per country predict outcomes with the infection, not the GDP of the country - A descriptive statistical analysis
P50
Q35540597-6883F9FE-748B-4277-9323-B293B9E9EC63Q37703688-E75759AA-FD05-415C-88F3-64A9D84F0EB7Q38198792-39AB830F-48CB-457F-A726-E835FEB2AFB6Q38282389-7E047F36-4A3A-4AD2-8AAF-DB4A9C5CB966Q41906566-47ACC80A-D105-4534-944E-06051E8F6B99Q51348909-0472A739-6115-44F4-AA23-A5BBD07CF9B0Q55020927-51E097F8-7D55-4CC0-A8DE-E63996080151Q65000335-5ACB9E2D-5790-454A-9A9B-49A4720CED6CQ89569330-8589DBAB-B9FA-47D7-B81B-A9934869F7BDQ90942216-48C11CA2-77E0-486C-9CFE-1BEEE69911C3Q91833868-AFABAA4B-CADA-4446-B0E8-CDC6996FDA6DQ91991330-B937AE0B-C8AA-42DD-B9EA-A3CE01DEA499Q91991336-6427A873-284F-44B6-A6CF-89C20B3AA1E3Q91991341-FF49124C-58AA-4CBD-A460-83620011917DQ92334528-8AC61E34-6000-4F45-99F3-87981E3EB89DQ92579552-AAAE3B75-CFBC-4CBF-91AC-123DE1069C59Q93159071-7CA4D8D1-8E8D-4F11-8766-A63A1A949A1FQ95601413-52026F10-CD0D-40A5-9AD8-A03DCE49C08EQ95610135-8DCDBF33-5140-45D1-8F14-7AF73442AA41
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Samit Ghosal
@ast
Samit Ghosal
@en
Samit Ghosal
@es
Samit Ghosal
@nl
type
label
Samit Ghosal
@ast
Samit Ghosal
@en
Samit Ghosal
@es
Samit Ghosal
@nl
prefLabel
Samit Ghosal
@ast
Samit Ghosal
@en
Samit Ghosal
@es
Samit Ghosal
@nl
P106
P31
P496
0000-0002-4141-5187